1. Statins and the prevention of stroke in diabetes

   • Mary Ann Banerji

   Invited Commentary Pages: 1 - 3

2. Web alert

   News Pages: 4 - 5

3. Clinical trials report

   • Eugene J. Barrett

   BriefCommunication Pages: 9 - 10

4. Atherosclerosis and restenosis: Is there a role for rage?

   • Peter Nawroth
   • Angelika Bierhaus
   • David M. Stern

   OriginalPaper Pages: 11 - 16

5. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

   • Louis J. Ignarro
   • Claudio Napoli

   OriginalPaper Pages: 17 - 23

6. Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes

   • Bart E. Muhs
   • Paul Gagne
   • Peter Sheehan

   OriginalPaper Pages: 24 - 29

7. FFAs: Do they play a role in vascular disease in the insulin resistance syndrome?

   • Sudha S. Shankar
   • Helmut O. Steinberg

   OriginalPaper Pages: 30 - 35

8. ACE inhibitors and mineralocorticoid receptor blockade in patients with congestive heart failure

   • John W. Funder

   OriginalPaper Pages: 36 - 40

9. Rimonabant: A novel treatment for obesity and the metabolic syndrome

   • Muhammad Houri
   • Richard E. Pratley

   Clinical Trials Report Pages: 43 - 44

10. PPAR ligands: Potential therapies for metabolic syndrome

    • Taro E. Akiyama
    • Peter T. Meinke
    • Joel P. Berger

    OriginalPaper Pages: 45 - 52

11. Interactions between obstructive sleep apnea and the metabolic syndrome

    • Anna Svatikova
    • Robert Wolk
    • Virend K. Somers

    OriginalPaper Pages: 53 - 58

12. Diabetes and brain aging: Epidemiologic evidence

    • Lenore J. Launer

    OriginalPaper Pages: 59 - 63

13. Erectile dysfunction: Interrelationship with the metabolic syndrome

    • Glenn Matfin
    • Ali Jawa
    • Vivian A. Fonseca

    OriginalPaper Pages: 64 - 69

14. The evolving role of inflammation in obesity and the metabolic syndrome

    • Yong-Ho Lee
    • Richard E. Pratley

    OriginalPaper Pages: 70 - 75